Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

BACKGROUND: Cefoxitin is active against some extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-PE), but has not been evaluated so far in the intensive care unit (ICU) settings. Data upon its pharmacokinetics (PK), tolerance and efficacy in critical conditions are scanty. We performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Chabert, Paul, Provoost, Judith, Cohen, Sabine, Dupieux-Chabert, Céline, Bitker, Laurent, Ferry, Tristan, Goutelle, Sylvain, Richard, Jean-Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522958/
https://www.ncbi.nlm.nih.gov/pubmed/36175707
http://dx.doi.org/10.1186/s13613-022-01059-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522958/
https://www.ncbi.nlm.nih.gov/pubmed/36175707
http://dx.doi.org/10.1186/s13613-022-01059-9

Ejemplares similares